Chronic pain is a unique pathophysiological state characterized by the formation of stable neurotransmitter, morphological, and behavioral patterns. Sleep has a facilitating influence on many pain syndromes by blocking signal conduction via the nociceptive pathways, the release of specific neurotransmitters, and the lack of conscious perception during this period. Restriction to the duration of sleep and impairment to its structure are accompanied by increased pain, while improvements in sleep in some cases allow pain to be decreased.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, H. Merskey and N. Bogduk (eds.), Prepared by the International Association for the Study of Pain and the Task Force on Taxonomy, IASP Press, Seattle (1994), 2nd ed.
N. N. Yakhno and M. L. Kukushkin (eds.), Pain: Practical Guidelines for Doctors, Russian Academy of Medical Sciences Press, Moscow (2011).
N. N. Yakhno and M. L. Kukushkin, “Chronic pain: medical-biological and social-economic aspects,” Vest. Ross. Akad. Med. Nauk., 9, 54–58 (2012).
H. Breivik, B. Collett, V. Ventafridda, R. Cohen, and D. Gallacher, “Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment,” Eur. J. Pain, 10, 287–333 (2006), https://doi.org/10.1016/j.ejpain.2005.06.009.
S. B. McMahon and M. Koltzenburg (eds.), Wall and Melzack’s Textbook of Pain, Elsevier Churchill Livingstone (2015), 5th ed.
D. Buskila, “Genetics of chronic pain states,” Best Pract. Res. Clin. Rheumatol., 21, 535–547 (2007), https://doi.org/10.1016/j.berh.2007.02.011.
M. L. Kukushkin and N. K. Khitrov, General Pain Pathology, Meditsina, Moscow (2004).
R. R. Edwards, “Genetic predictors of acute and chronic pain,” Curr. Rheumatol. Rep., 8, 411–417 (2006), https://doi.org/10.1007/s11926-006-0034-2.
L. Diatchenko, G. D. Slade, A. G. Nackley, K. Bhalang, A. Sigurdsson, I. Belfer, D. Goldman, K. Xu, S. A. Shabalina, D. Shagin, M. B. Max, S. S. Makarov, and W. Maixner, “Genetic basis for individual variations in pain perception and the development of a chronic pain condition,” Hum. Mol. Genet., 14, No. 1, 135–143 (2005), https://doi.org/10.1093/hmg/ddi013.
M. L. Lacroix-Fralish and J. S. Mogil, “Progress in genetic studies of pain and analgesia,” Annu. Rev. Pharmacol. Toxicol., 49, 97–121 (2009), https://doi.org/10.1146/annurev-pharmtox-061008-103222.
F. Seifert and C. Maihofner, “Functional and structural imaging of pain-induced neuroplasticity,” Curr. Opin. Anaesthesiol., 24, 515–523 (2011), https://doi.org/10.1097/ACO.0b013e32834a1079.
A. K. Jetzer, A. Morel, M. Magnin, and D. Jeanmonod, “Crossmodal plasticity in the human thalamus: evidence from intraoperative macrostimulations,” Neuroscience, 164, 1867–1875 (2009), https://doi.org/10.1016/j.neuroscience.2009.09.064.
M. G. Pshennikova, V. S. Smirnova, V. N. Grafova, M. V. Shimkovich, I. Yu. Malyshev, and M. L. Kukushkin, “Resistance to the development of neuropathic pain syndrome in August rats and a population of Wistar rats with different innate levels of resistance to stress,” Bol’, 2, 13–16 (2008).
D. Buskila, P. Sarzi-Puttini, and J. N. Ablin, “The genetics of fibromyalgia syndrome,” Pharmacogenomics, 8, 67–74 (2007), https://doi.org/10.2217/146224184.108.40.206.
A. V. Osipov and M. L. Kukushkin, “Effects of stress on the development of deafferentation pain syndrome in rats after transection of the sciatic nerve,” Byull. Eksperim. Biol. Med., 115, No. 5, 471–473 (1993).
E. Kohlschütter, “Messungen der Festigkeit des Schlafes,” Z. Ration. Med., 17, 209–253 (1863).
M. Steriade, D. A. McCormick, and T. J. Sejnowski, “Thalamocortical oscillations in the sleeping and aroused brain,” Science, 262, No. 5134, 679–685 (1993).
J. H. Peever and B. J. Sessle, “Sensory and motor processing during sleep and wakefulness,” in: Principles and Practice of Sleep Medicine, M. H. Kryger, T. Roth, and W. C. Dement (eds.), Elsevier, Philadelphia (2016).
G. Sandrini, I. Milanov, B. Rossi, L. Murri, E. Alfonsi, A. Moglia, and G. Nappi, “Effects of sleep on spinal nociceptive reflexes in humans,” Sleep, 24, No. 1, 13–17 (2001).
S. S. Ødegård, P. M. Omland, K. B. Nilsen, M. Stjern, G. B. Gravdahl, and T. Sand, “The effect of sleep restriction on laser evoked potentials, thermal sensory and pain thresholds and suprathreshold pain in healthy subjects,” Clin. Neurophysiol., 126, No. 10, 1979–1978 (2015), https://doi.org/10.1016/j.clinph.2014.12.011.
T. Roehrs, M. Hyde, B. Blaisdell, M. Greenwald, and T. Roth, “Sleep loss and REM sleep loss are hyperalgesic,” Sleep, 29, No. 2, 145–151 (2006).
T. A. Roehrs, E. Harris, S. Randall, and T. Roth, “Pain sensitivity and recovery from mild chronic sleep loss,” Sleep, 35, No. 12, 1667–1672 (2012), https://doi.org/10.5665/sleep.2240.
P. H. Finan, B. R. Goodin, and M. T. Smith, “The association of sleep and pain: An update and a path forward,” Pain, 14, No. 12, 1539–1552 (2013), https://doi.org/10.1016/j.jpain.2013.08.007.
M. T. Smith and J. A. Haythornthwaite, “How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature,” Sleep Med. Rev., 8, 119–132 (2004), https://doi.org/10.1016/S1087-0792(03)00044-3.
D. J. Taylor, L. J. Mallory, K. L. Lichstein, H. H. Durrence, B. W. Riedel, and A. J. Bush, “Comorbidity of chronic insomnia with medical problems,” Sleep, 30, 213–218 (2007).
M. T. Smith, M. Perlis, M. S. Smith, D. E. Giles, and T. P. Carmody, “Sleep quality and presleep arousal in chronic pain,” J. Behav. Med., 23, 1–13 (2000).
L. Kelman, “The triggers or precipitants of the acute migraine attack,” Cephalalgia, 27, 394–402 (2007), https://doi.org/10.1111/j.1468-2982.2007.01303.x.
P. K. Sahota and J. D. Dexter, “Sleep and headache syndromes: A clinical review,” Headache, 30, 80–84 (1990).
P. R. Holland, “Headache and sleep: Shared pathophysiological mechanisms,” Cephalalgia, 34, No. 10, 725–744 (2014), https://doi.org/10.1177/0333102414541687.
E. B. Arushanyan and E. V. Beier, “The epiphyseal hormone melatonin – a universal natural adaptogen,” Usp. Fiziol. Nauk., 43, No. 2, 82–100 (2012).
E. B. Arushanyan, “Comparative assessment of epiphyseal melatonin and benzodiazepine anxiolytics,” Eksp. Klin. Farmakol., 75, No. 3, 35–40 (2012).
C. Laurido, T. Pelissie, R. Soto-Moyano, L. Valladares, F. Flores, and A. Hernandez, “Effect of melatonin on rat spinal cord nociceptive transmission,” Neuroreport, 13, No. 1, 89–91 (2002).
S. M. El-Shenawy, O. M. Abdel-Salam, A. R. Baiuomy, S. El-Batran, and M. S. Arbid, “Studies on the inflammatory and anti-nociceptive effect of melatonin in the rat,” Pharmacol. Res., 46, 3:235–243 (2002).
M. Ambriz-Tututi and V. Granados-Soto, “Oral and spinal melatonin reduces tactile allodynia in rats via activation of MT2 and opioid receptors,” Pain, 132, 3:273–280 (2007), https://doi.org/10.1016/j.pain.2007.01.025.
V. Srinivasan, E. C. Lauterbach, K. Y. Ho, D. Acuna-Castroviejo, R. Zakaria, and A. Brzezinski, “Melatonin in antinociception: Its therapeutic applications,” Curr. Neuropharmacol., 10, 167–178 (2012), https://doi.org/10.2174/157015912800604489.
M. Wilhelmsen, I. Amirian, R. J. Reiter, J. Rosenberg, and I. Gogenur, “Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies,” J. Pineal Res., 51, No. 3, 270–277 (2011), https://doi.org/10.1111/j.1600-079X.2011.00895.x.
S. A. Hussain, H. Al-Khalifa, N. A. Jasim, and F. I. Gorial, “Adjuvant use of melatonin for treatment of fibromyalgia,” J. Pineal Res., 50, 267–271 (2011), https://doi.org/10.1111/j.1600-079X.2010.00836.x.
V. M. Koval’zon, “The role of the orexinergic system of the brain in regulating waking and sleep,” Effektiv. Farmakoter. Nevrol. Psikhiatr., Spec. Iss., Sleep and Its Disorders-4, 19, 6–14 (2016).
T. Yamamoto, N. Nozaki-Taguchi, and T. Chiba, “Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test,” Brit. J. Pharmacol., 137, 170–176 (2002), https://doi.org/10.1038/sj.bjp.0704851.
I. V. Estabrooke, M. T. McCarthy, E. Ko, T. C. Chou, R. M. Chemelli, M. Yanagisawa, C. B. Saper, and T. E. Scammell, “Fos expression in orexin neurons varies with behavioral state,” J. Neurosci., 21, No. 5, 1656–1662 (2001).
S. V. Mahler, D. E. Moorman, R. J. Smith, M. H. James, and G. Aston- Jones, “Motivational activation: a unifying hypothesis of orexin/hypocretin function,” Nat. Neurosci., 17, 1298–1303 (2014), https://doi.org/10.1038/nn.3810.
A. Inutsuka, A. Yamashita, S. Chowdhur, J. Nakai, M. Ohkura, T. Taguchi, and A. Yamanaka, “The integrative role of orexin/hypocretin neurons in nociceptive perception and analgesic regulation,” Sci. Rep., 6, 29480 (2016), https://doi.org/10.1038/srep29480.
M. G. Poluektov (ed.), Somnology and Sleep Medicine: National Guidelines in Memory of A. M. Vein and Ya. I. Levin, Medforum, Moscow (2016).
S. R. Currie, K. G. Wilson, and D. Curran, “Clinical significance and predictors of treatment response to cognitive-behavior therapy for insomnia secondary to chronic pain,” J. Behav. Med., 25, 135–153 (2002).
J. D. Edinger, W. K. Wohlgemuth, A. D. Krystal, and J. R. Rice, “Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial,” Arch. Intern. Med., 165, No. 21, 2527–2535 (2005), https://doi.org/10.1001/archinte.165.21.2527.
M. Vitiello, B. Rybarczyk, and E. Stephanski, “Sleep as analgesic: improving sleep and pain in older adults [abstract No. 0302],” Sleep, 30, Suppl. A, 103–194 (2007).
N. K. Tang, “Cognitive-behavioral therapy for sleep abnormalities of chronic pain patients,” Curr. Rheumatol. Rep., 11, No. 6, 451–460 (2009).
M. Grönblad, J. Nykanen, Y. Konttinen, E. Jarvinen, and T. Helve, “Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial,” Clin. Rheumatol., 12, 186–191 (1993).
H. Moldofsky, F. A. Lue, C. Mously, B. Roth-Schechter, and W. J. Reynolds, “The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study,” J. Rheumatol., 23, 529–533 (1996).
T. A. Roehrs, “Does effective management of sleep disorders improve pain symptoms?” Drugs, 69, No. 2, 5–11 (2009), https://doi.org/10.2165/11531260-000000000-00000.
J. K. Walsh, M. J. Muehlbach, S. A. Lauter, N. A. Hilliker, and P. K. Schweitzer, “Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis,” J. Rheumatol., 23, No. 2, 245–252 (1996).
P. Morillas-Arques, C. M. Rodriguez-Lopez, R. Molina-Barea, F. Rico-Villademoros, and E. P. Calandre, “Trazodone for the treatment of fibromyalgia: an open-label, 12-week study,” BMC Musculoskelet. Disord., 11, 204 (2010), https://doi.org/10.1186/1471-2474-11-204.
B. Saletu, W. Prause, P. Anderer, M. Mandl, M. Aigner, O. Mikova, and G. M. Saletu-Zyhlarz, “Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24×7 and the Siesta database,” Neuropsychobiology, 51, No. 3, 148–63 (2005), https://doi.org/10.1159/000085207.
M. G. Poluektov, Ya. I. Levin, V. A. Mikhailov, S. L. Babak, and K. N. Strygin, “Use of Trittico (trazodone) for the treatment of sleep impairments in depression: results of a multicenter trial,” Effektiv. Farmakoter. Nevrol. Psikhiatr., Spec. Iss., Sleep and Its Disorders, 12, 82–90 (2013).
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 117, No. 4, Iss. II, Sleep Disorder, pp. 19–27, April, 2017.
About this article
Cite this article
Kukushkin, M.L., Poluektov, M.G. Current Views on Chronic Pain and Its Relationship to the State of Sleep. Neurosci Behav Physi 49, 13–19 (2019). https://doi.org/10.1007/s11055-018-0684-3
- chronic pain